Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Moderna stock surges as melanoma vaccine trial shows "landmark moment"https://wpnnradio.com/wp-content/themes/movedo/images/empty/thumbnail.jpg150150adminadminhttps://secure.gravatar.com/avatar/790df65a416873c3f0501d984b0b24a2f32bf2af0d1509085b901ade4bbb36e7?s=96&d=mm&r=g
Moderna and Merck announced study results that reflect a “landmark moment” in treatment for one of the deadliest forms of skin cancer. source
